11:00 - 11:30 | Introduction and objectives of the meeting A. Antinori, A. d’Arminio Monforte |
11:30 - 12:00 | OPENING LECTURE Chair: A. Lazzarin |
Milestones of ICONA advances of knowledge on HIV: a 25 years’ story A. d’Arminio Monforte | |
SESSION 1 - Real-Life Studies On Antiretroviral Therapy-1Chairs: A. Lazzarin, E. Quiros-Roldan |
|
REGISTRIES ON INDIVIDUAL REGIMENS AND ART EFFECTIVENESS |
|
12:00 - 12:10 | Real life study of PLWH initiating BIC/FTC/TAF as naïve or experienced A. Tavelli |
12:10 - 12:20 | Real life study on PLWH initiating 3TC-DTG as first line therapy S. Lo Caputo |
12:20 - 12:30 | Criteria of doravirine choice in naïve and experienced in the ICONA cohort A. Saracino |
12:30 - 12:40 | Changes of body weight and of plasma lipidome in PLWH starting double or triple INSTI regimens F. Bai |
12:40 - 12:50 | Predictors of starting dual DTG as naïve and experienced N. Gianotti, A. Vergori |
12:50 - 13:00 | EPICO Study: EPIdemiology and Comorbidities of people living with HIV (PLWH) SWITHCHing to current therapeutic strategies A. Cozzi-Lepri |
13:00 - 13:20 | Discussion |
13:20 - 14:10 | Lunch |
14:10 - 15:10 | ROUND TABLE: THE ROLE OF ICONA COHORT ON ANTIRETROVIRAL THERAPY IN 2023 AND BEYOND Presenters: A. Castagna, F. Maggiolo Discussants: C. Pinnetti, S. Rusconi, B. Suligoi |
SESSION 2 - HIV And CoinfectionsChairs: G.V. Calvino, G. Guaraldi |
|
LECTURES |
|
15:10 - 15:25 | COVID-19 and Monkeypox: what impacts on PLWH? A. Antinori |
15:25 - 15:40 | How anti-SARS-CoV-2 prophylaxis and therapy changed the natural course of COVID-19 C. Mussini |
15:40 - 16:00 | Discussion |
COVID-19, MPX AND HIV: DATA FROM ICONA |
|
16:00 - 16:10 | Impact of COVID-19 on linkage to HIV care G. Madeddu |
16:10 - 16:20 | Impact of COVID-19 on viral suppression and retention to care R. Gagliardini |
16:20 - 16:30 | Monkeypox and the ICONA Cohort V. Mazzotta |
16:30 - 17:00 | Session key points and discussion on ICONA perspectives M. Cernuschi, A. Giacomelli, S. Lanini |
17:00 - 17:15 | Coffee break |
SESSION 3 - Hepatitis In The ICONA CohortChairs: L. Sarmati |
|
LECTURES |
|
17:15 - 17:30 | New strategies to get to zero hepatitis infections E. Girardi |
17:30 - 17:45 | Role of lab in detecting HDV-associated liver disease V. Svicher |
17:45 - 18:00 | Discussion |
HBV, HDV, HCV: DATA FROM ICONA |
|
18:00 - 18:10 | Natural history of HDV infection in the ICONA cohort: candidates to new therapies M. Puoti |
18:10 - 18:20 | NoCo study: long-term follow-up A. d’Arminio Monforte |
18:20 - 18:50 | Session key points and discussion on ICONA perspectives F. Ceccherini Silberstein, R. Rossotti |
SESSION 4 - Anti-SARS CoV-2 Vaccine Outcomes In The ICONA CohortChairs: S. Antinori. A. Gori, G. Rizzardini |
|
LECTURE |
|
08:45 - 09:00 | New vaccines, new diseases: what in the present and in pipeline - C.F. Perno |
09:00 - 09:10 | Discussion |
SARS-COV-2 VACCINES: DATA FROM ICONA |
|
09:10 - 09:20 | Humoral response to anti-SARS-CoV-2 vaccines: the Orchestra study A. Vergori |
09:20 - 09:30 | Cellular response to anti-SARS-CoV-2 vaccines: the Orchestra study G.C. Marchetti |
09:30 - 10:00 | Session key points and discussion on ICONA perspectives A. Bandera, A. Di Biagio |
SESSION 5 - ICONA New ProjectsChairs: A. Castagna, F. Schlosser |
|
10:00 - 10:10 | First results from the App ‘e-QoL’ of ICONA cohort and next implementations A. Cingolani |
10:10 - 10:20 | ICONA XT: report of the events and suggestions for future initiatives for young researchers D. Barbanotti, A. d’Arminio Monforte |
10:20 - 10:30 | Long-ICONA: the project and a photo of the first included PLWH A. Rodanò |
10:30 - 10:40 | ICONA data: from the report to the newsletter S. Lo Caputo |
10:40 - 11:10 | Session key points and discussion on ICONA perspectives M.L. Cosmaro, M. Lichtner |
11:10 - 11:25 | Coffee break |
SESSION 6 - Future Research Topics In The ICONA Cohort |
|
ROUND TABLE - THE CURE AGENDA: WHAT POSSIBLE ICONA CONTRIBUTIONSChair: C.F. PernoPresenters: A. Calcagno, F. Ceccherini Silberstein, G.C. Marchetti Discussants: All members of Scientific Secretary of ICONA |
|
SESSION 7 - Meeting Restricted To ICONA Centers |
|
12:25 - 13:45 | Discussion with centers I. Fanti, A. Rodanò, A. Tavelli, T. White |
13:45 - 14:00 | Closing Remarks A. Antinori, A. d’Arminio Monforte |